- US12577245utility2026Sulfonyl Benzamide Derivatives as Bcl-2 Inhibitors0 cites
- US12528832utility2026Crystalline or Amorphous Form of Bcl-2/bcl-xl Inhibitor Compound or Its Salts0 cites
- US12358912utility2025Crystalline Forms or Amorphous Forms of N-(phenyl Sulfonyl) Benzamide Compounds or Its Salts or Solvates0 cites
- US12343352utility2025N-(phenylsulfonyl)benzamides and Related Compounds as Bcl-2 Inhibitors0 cites
- US12319703utility2025Macrocyclic Fused Pyrazoles as Mcl-1 Inhibitors0 cites
- US12287338utility2025Method and Compositions for Predicting Anti-cancer Efficacy of Compounds Targeting Apoptosis Pathway0 cites
- US12233047utility2025Pharmaceutical Combination and Use Thereof0 cites
- US12221427utility2025Preparation Method of (5-fluoro-2,3-dihydrobenzofuran-4-yl)methanamine or Its Salt, and Intermediates Thereof0 cites
- US12194024utility2025Pharmaceutical Composition of MDM2 Inhibitor and Use Thereof for Preventing And/or Treating Disease0 cites
- US11987575utility2024Tricyclic Compounds as BCR-ABL Inhibitors0 cites
- US11872237utility2024Pharmaceutical Composition and Preparation Method Thereof0 cites
- US11850239utility2023MDM2 Inhibitor and a Platinum Compound for Cancer Treatment0 cites
- US11787814utility2023Method for Preparing 2-indolinospirone Compound and Intermediate Thereof0 cites
- US11691989utility2023Macrocyclic Indoles as Mcl-1 Inhibitors0 cites